Clinical Trial Update: Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of focused ultrasound ablation with PD-1 antibody blockade in advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Melanoma
• Merkel Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Squamous Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Focused ultrasound ablation (Focused ultrasound ablation)
• PD-1 antibody blockade (PD-1 inhibitor)

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Melanoma, Breast Cancer | Phase 1 | Status: TERMINATED